Brittle bone disease; Congenital disease; OI
Osteogenesis imperfecta is a condition causing extremely fragile bones.
Osteogenesis imperfecta (OI) is present at birth. It is often caused by a defect in the gene that produces type 1 collagen, an important building block of bone. There are many defects that can affect this gene. The severity of OI depends on the specific gene defect.
If you have 1 copy of the gene, you will have the disease. Most cases of OI are inherited from a parent. However, some cases are the result of new genetic mutations.
A person with OI has a 50% chance of passing on the gene and the disease to his or her children.
All people with OI have weak bones, and fractures are more likely. People with OI are most often below average height (short stature). However, the severity of the disease varies greatly.
The classic symptoms include:
Because type I collagen is also found in ligaments, people with OI often have loose joints (hypermobility) and flat feet. Some types of OI also lead to the development of poor teeth.
Symptoms of more severe forms of OI may include:
OI is most often suspected in children whose bones break with very little force. A physical exam may show that the whites of their eyes have a blue tint.
A definitive diagnosis may be made using a skin punch biopsy. Family members may be given a DNA blood test.
If there is a family history of OI, chorionic villus sampling may be done during pregnancy to determine if the baby has the condition. However, because so many different mutations can cause OI, some forms cannot be diagnosed with a genetic test.
The severe form of type II OI can be seen on ultrasound when the fetus is as young as 16 weeks.
There is not yet a cure for this disease. However, specific therapies can reduce the pain and complications from OI.
Drugs that can increase the strength and density of bone are used in people with OI. They have been shown to reduce bone pain and fracture rate (especially in the bones of the spine). They are called bisphosphonates.
Low impact exercises, such as swimming, keep muscles strong and help maintain strong bones. People with OI can benefit from these exercises and should be encouraged to do them.
In more severe cases, surgery to place metal rods into the long bones of the legs may be considered. This procedure can strengthen the bone and reduce the risk for fracture. Bracing can also be helpful for some people.
Surgery may be needed to correct any deformities. This treatment is important because deformities (such as bowed legs or a spinal problem) can interfere with a person's ability to move or walk.
Even with treatment, fractures will occur. Most fractures heal quickly. Time in a cast should be limited, because bone loss may occur when you do not use a part of your body for a period of time.
Many children with OI develop body image problems as they enter their teenage years. A social worker or psychologist can help them adapt to life with OI.
How well a person does depends on the type of OI they have.
There are other types of OI, but they occur very rarely and most are considered subtypes of the moderately severe form (type IV).
Complications are largely based on the type of OI present. They are often directly related to the problems with weak bones and multiple fractures.
Complications may include:
Severe forms are most often diagnosed early in life, but mild cases may not be noted until later in life. See your health care provider if you or your child have symptoms of this condition.
Genetic counseling is recommended for couples considering pregnancy if there is a personal or family history of this condition.
Deeney VF, Arnold J. Orthopedics. In: Zitelli BJ, McIntire SC, Norwalk AJ, eds. Zitelli and Davis' Atlas of Pediatric Physical Diagnosis. 7th ed. Philadelphia, PA: Elsevier; 2018:chap 22.
Marini JC. Osteogenesis imperfecta. In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF, eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016:chap 701.BACK TO TOP
Review Date: 9/5/2017
Reviewed By: Neil K. Kaneshiro, MD, MHA, Clinical Professor of Pediatrics, University of Washington School of Medicine, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2019 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.